S&P 500: 686.38 +0.1% NASDAQ 100: 608.09 +0.1% Dow Jones: 489.18 -0.1%

FibroBiologics, Inc.

FBLG Healthcare
$0.41 +$0.09 (24.89%)
Market Cap: $27.74 M
Gurus Holding
2
Popularity Rank
#3657
% of Shares Held
0.37%
Net Activity (Q4 2025)
+$41,893.94

Guru Ownership Trend

Guru Analysis for FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc. (FBLG), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $100,989.59.

Top institutional holders include Renaissance Technologies and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $41,893.94 net inflow during the quarter.

Recent activity highlights Renaissance Technologies who increased their stake by 287.3%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$41,893.94
Total Buy Value
New Buys 1
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for FibroBiologics, Inc. (FBLG)

Major holders include Renaissance Technologies ($52,087), Steven Cohen ($3,256). According to the latest reported data, 2 tracked investment managers collectively hold approximately 246,076 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $41,893.94, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in FBLG during the most recent reporting period.

Yes, 1 managers opened new positions in FBLG, and 1 increased their existing holdings. The total reported buy value was $41,893.94.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 287.3% 231,600 $52,087 Q4 2025
0.00% New Buy 14,476 $3,256 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form